WALNUT CREEK, Calif. - March 21, 2022 - (Newswire.com) Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately-held oncology company focused on tough-to-treat cancers, is honored to welcome, Dr. David Reardon, MD, Professor of Medicine at Harvard Medical School and Clin.
WALNUT CREEK, Calif. - November 22, 2021 - (Newswire.com) Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will present its lead development candidate, AR-67, at this year's 5th Meridian Clinical Trials (MCT) conference, Nov. 22-23, 2021.